Biotech Sector $XBI Hits $97, Eyes Potential Breakout Near $94-95 Levels in Q3

$XBI, the biotech sector, has been performing strongly with highs up 2.1%. Analysts are optimistic about a potential breakout as it has been making higher lows and setting up near 94-95 levels. Traders are watching for a breakout at the 200dma or 20mma. The stock is currently at $97, having hit $203 in February. Biotech is considered one of the top sectors for Q3.